Ph.D. WEI-WU HE - 15 Jun 2021 Form 4 Insider Report for CASI Pharmaceuticals, Inc.

Role
Chairman and CEO, Director, 10%+ Owner
Signature
/s/ Cynthia W. Hu, attorney-in-fact for Wei Wu He
Issuer symbol
N/A
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 16:01:20 UTC
Next filing
20 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CASI Stock Options (Right to Buy) Award $0 +4,000,000 $0.000000 4,000,000 15 Jun 2021 Common Stock 4,000,000 $1.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved by the Board of Directors on April 27, 2021, subject to stockholder approval of the option grant. The Company's stockholders approved the option grant on June 15, 2021.
F2 The stock options will vest as follows: 25 percent on each of the first, second, third and fourth anniversaries of the date of grant.